Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Community-viable Screening for Autism Spectrum Disorder (ASD) in 9-month-old Infants Using Quantitative Eye-tracking Assays of Social Visual Engagement

NCT05916430 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT05916430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05916430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Community-viable Screening for Autism Spectrum Disorder (ASD) in 9-month-old Infants Using Quantitative Eye-tracking Assays of Social Visual Engagement
Lead sponsor
Emory University
Phase
Observational
Overall status
Recruiting
Start date
February 2, 2023
Completion date
December 31, 2027
Enrollment
2,120 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

autism, infant development